Neumora Therapeutics Inc ( NMRA ) shares plummeted after the FDA placed a clinical hold on the company’s Phase 1 trial of NMRA-266. NMRA-266 is a positive allosteric modulator (PAM) of the M4 muscarinic receptor and is part of the Company’s M4 PAM franchise.  The clinical hold determination follows recently available preclinical data showing convulsions in rabbits. Following this action, the Phase...

10:18 AM EDT, 04/15/2024 (MT Newswires) -- (Updates to add stock move in the headline and the first paragraph.) Tesla (TSLA) shares were 3.5% lower in recent trading Monday after multiple media outlets reported that the company has told employees in an internal email that it plans to lay off more than 10% of its workforce worldwide. We have done...

10:26 AM EDT, 04/15/2024 (MT Newswires) -- Medical Properties Trust ( MPW ) shares jumped more than 19% in recent trading on Monday after announcing late Friday that it has sold its majority stake in five Utah hospitals to a new joint venture with an investment fund linked to an unnamed asset manager. The company is keeping an about 25%...

April 15 (Reuters) - British commodities platform Marex Group said on Monday it is seeking a valuation of up to $1.49 billion in its initial public offering in the United States joining the list of foreign companies turning to U.S. capital markets. The company said in a filing it is offering to sell about 15.4 million shares at a price...